Dr. Forman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6503
Education & Training
- University of Pennsylvania Health SystemFellowship, Neuropathology, 1998 - 2003
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1996 - 1998
- Duke University School of MedicineClass of 1995
Certifications & Licensure
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 14 citationsSafety, Tolerability, and Pharmacokinetics of the β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor Verubecestat (MK-8931) in Healthy Elderly Male and Femal...Mark S. Forman, John Palcza, Jack Tseng, Julie A. Stone, Brittany Walker
Clinical and Translational Science. 2019-09-01 - 16 citationsPharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study.K Chris Min, Marissa F. Dockendorf, John Palcza, Jack Tseng, Lei Ma
Clinical Pharmacology and Therapeutics. 2019-05-01 - 76 citationsBrain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary TanglesTalakad G. Lohith, Idriss Bennacef, Rik Vandenberghe, Mathieu Vandenbulcke, Cristian Salinas
Journal of Nuclear Medicine. 2019-01-01
Grant Support
- Core--NeuropathologyNational Institute On Aging2006–2010
- Mechanisms Of Tau-Based NeurodegenerationNational Institute On Aging2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: